NorthWest Biotherapeutics Inc (NWBO)

[gnawkz]

Yes, absolutely. To build out a whole manufacturing line for volume commercial production, pass FDA cGMP audits, and set up the necessary partnerships with hospitals and medical suppliers only to have the drug not get approved? That is TREMENDOUS risk for the business with very limited upside. This doesn't include the opportunity cost of using that space for developing generics, approved therapies, or even loaning it out to Big Pharma for cash.

To make sure everyone understands, I am only referring to the commercial build out of the production line. Clinical trial manufacturing is small, can be performed on a one-off basis, and thus completely viable for any contract manufacturer to take on. That is not what is being argued here.

Only the full commercial build out required by the FDA for final Cell Therapy Approval.